Top in cardiology: Dual vaping/cigarette use, COVID-19 hospitalization

Dual vaping and traditional cigarette use induced responses that are similar to stresses caused by traditional cigarette use, nationally representative data showed. It was the top story in cardiology last week.

Another top story discussed certain sociodemographic characteristics that increased the mortality rate in patients hospitalized for COVID-19.

Read these and more top stories in cardiology below.

Dual vaping/cigarette use may be no safer than tobacco cigarette use alone

E-cigarette use combined with use of traditional cigarettes may confer similar inflammatory and oxidative stress to exclusive use of traditional cigarettes, according to research published in Circulation. Read more.

Age, sex, comorbidities impact outcomes after COVID-19 hospitalization

In a national private health care database, age, male sex and comorbidities increased risk for death in patients hospitalized with COVID-19, according to data presented at the virtual American Heart Association Scientific Sessions. Read more.

COLCOT: Colchicine beneficial in patients with diabetes, recent MI

Patients with diabetes and recent myocardial infarction had reduced risk for first and total cardiovascular events with colchicine compared with placebo, according to new data from the COLCOT trial. Read more.

Children with congenital heart disease likelier to have anxiety, depression, ADHD

Children with congenital heart disease are significantly more likely to have anxiety, depression or ADHD, according to data from a Texas hospital. Read more.

Renin-angiotensin inhibitors safe in patients hospitalized with COVID-19: REPLACE COVID

It is safe for patients hospitalized with COVID-19 to continue using renin-angiotensin system inhibitors, researchers reported. Read more.